Skip to content
PeptideFactSheets

Growth-hormone secretagogue · Fact sheet

Hexarelin

Also known as Examorelin

Hexarelin stimulates growth hormone and can also affect other hormones. Small human experiments do not prove muscle or recovery benefits, and one sleep study found less deep sleep rather than an improvement.

Not FDA approvedEarly human evidence
Muscle & recoveryHormones & sexual healthBrain, mood & sleep

What is Hexarelin?

Hexarelin is a synthetic peptide studied through the growth-hormone secretagogue pathway. It is not selective for a single hormone response under every experimental condition.

Benefits people look for

Muscle growth, recovery, and deeper sleep are common expectations. The available human studies mainly measure hormones, and some findings run against the sleep claim.

What the evidence supports

  • Acute studies document growth-hormone release, with prolactin and cortisol changes under some conditions.
  • The longer endocrine study did not find persistent overstimulation of the measured adrenal and prolactin responses; this is narrower than proving overall safety.
All research areas
  • Growth-hormone secretion
  • Pituitary-adrenal signaling
  • Sleep architecture

Anecdotal reports & lived experiences

Reports describe what someone noticed. They cannot establish cause, typical results, or how often a side effect happens.

No attributable personal reports are summarized here yet. The benefits above describe research interests; the side effects below come from the cited medical sources.

We do not fill this gap with unsourced testimonials or estimated success rates.

Side effects & risks

  • A seven-person experiment found reduced stage-4 sleep and delta activity, with increased cortisol and other hormones.
  • Acute and repeated-exposure findings differ, so a single hormone result cannot predict long-term effects.

This is a summary of the cited evidence, not a complete product label. A lack of human safety data does not establish safety.

Clinical research: how strong is it?

Early human evidence

Acute endocrine experiments and small short-term studies demonstrate biological activity. A seven-person sleep study and a 16-week endocrine study are too limited to establish broad benefits or long-term safety.

Selected research to read

FDA approval & research status

Hexarelin has no FDA-approved therapeutic product. The cited endocrine experiments document historical human research, not an established approved recovery or sleep treatment.

No FDA-approved use is documented in the records summarized on this page.

Historical human studies; no FDA approval

Hexarelin has no FDA-approved therapeutic product. The cited endocrine experiments document historical human research, not an established approved recovery or sleep treatment.

This summarizes the cited product or research record. Trial phases do not establish successful completion of earlier stages, and a stopped program is not ongoing development. Approval applies only to the labeled product, use and population.

What we still don’t know

  • Clinical benefits for muscle or injury recovery
  • Long-term metabolic and endocrine safety
  • Whether effects differ across populations and products

The takeaway

Hexarelin has measurable hormone effects, but little evidence that those changes deliver the consumer benefits often claimed.

Sources & further reading

Medical evidence and regulatory sources are listed here. Personal reports are linked separately in the experiences section.

  1. 1
    pubmedHexarelin endocrine responses in humans

    Acute growth-hormone, prolactin, and cortisol response study.

  2. 2
    pubmedHexarelin and human sleep-endocrine activity

    Seven-volunteer study showing reduced deep-sleep measures.

  3. 3
    pubmedRepeated hexarelin exposure and the pituitary-adrenal axis

    16-week study; no persistent adrenal or prolactin overstimulation in the measured outcomes.

How we assess sources · Suggest a correction